![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
- Bhaumik J. and Hill N.C.W. (2000) Elevated CA125 levels in association with endometriosis. Journal of Obstetrics and Gynaecology, 20, 207.
- Johansson J., Santala M. and Kauppila A. (1998) Explosive rise of serum CA12S following the rupture of ovarian endometri oma. Human Reproduction , 13, 3503-3504.
- Kashyap R.J. (1999) Extremely elevated serum C A-125 due to endometriosis. Australian and New Zealand Journal of Obstetrics and Gynaecology, 39, 269-270.
- Watermeyer S.R., Chin K. and Evans A.S. (1999) Caution is required in interpreting high levels of CA-125 in patients with a pelvic mass. Journal of Obstetrics and Gynaecology, 19, 323.
- Berkow R. (ed.) (1992) The Merck Manual of Diagnosis and Therapy. Merck Research Laboratories.
- HMSO (1996) Confidential enquiries into Maternal Deaths in the United Kingdom 1991-1993. HMSO, London.
- Nelson-Piercy C. (1998) Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken? Drug Safety, 19, 155-164.
- Young LY. and Koda-Kimble M.A. (1995) Applied Therapeutics: the clinical use of drugs. Sixth edition. Vancouver, Applied Therapeutics Inc.
Journal of Obstetrics and Gynaecology
Volume 21, 2001 - Issue 5